Congratulations to Chris Su MD MPH for his JCO publication on the impact of the Affordable Care Act in lowering the financial burden for younger cancer survivors ascopubs.org/doi/abs/10.120… Read his interview here: labblog.uofmhealth.org/rounds/financi… U-M Rogel Cancer Center Chris Friese, RN, PhD

💵 #ASH21 Poster Walk on #FinancialToxicity in Hematologic Malignancies ⭐ Featuring #HemeTwitter stars like Chris Su MD MPH, Asher Chanan-Khan, & Gaurav Goyal! Click here: loom.ly/VuMg8dY #leusm #lymsm #HealthDisparities

thanks to ASH for giving us this platform. really proud of the great work by all of the poster presenters!😊financial toxicity is an old tale, but it's a developing story with lots of progress to be made in the future.📈proud to be a researcher in this field!💪

Nick Genes beat me to the punch, but excited for our new paper examining antibiotic stewardship in telemedicine. Health system-affiliated emergency physicians prescribed antibiotics much less often than contractor-supplied docs for ARI visits (almost always viral). (1/5)

Patients with #bloodcancers attended more medical visits and were more worried about paying #medicalbills compared to those with solid tumors, finds research from Chris Su MD MPH Christine Veenstra Minal R. Patel mdpi.com/2072-6694/14/7…

many thanks to JCO Oncology Practice. #FinTox faced by patients with heme malignancies deserves dedicated research. ascopubs.org/doi/full/10.12…

#JCOOP Editorial Chris Su MD MPH: As we continue to seek financial equity in cancer care, there is not a one-size-fits-all approach. The unique voices & tx journeys of patients w/ #hematologicmalignancies deserve dedicated attention. fal.cn/3qh5K #financialtoxicity

Great to meet with staff Sen. Maria Cantwell to advocate for nih funding and sickle cell disease awareness for ASH #Fight4Hematology #ConquerSCD

thanks ASH for the amazing experience in Washington DC to advocate for important hematology initiatives including funding to #NIH and #CDC to #ConquerSCD and #Fight4Hematology. best conference (yet) this year! 😆🩸

I started reading NatureRevClinOncol since fellowship for the great reviews! 🥹 thank you for the opportunity and Veena Shankaran MD, MS for the mentorship🤩

by far my favorite photo from ASH - with UM Hematology/Oncology Fellowship alumni! our paths may have taken us to 3 different time zones, but we are united in our love of Red, the ASH mascot😉

first article together with Kathleen Li, MD MS! get your COVID vaccines 💉 seattletimes.com/opinion/why-na…

Thank you Oncology Data Advisor for the opportunity to share our research!

Great to see our #MMsm work out in CLML! For patients living with myeloma: 1️⃣ Financial toxicity risk the same regardless of disease status 2️⃣ 37% of patients on maintenance reported 'time toxicity.' More interventions in this space coming soon! clinical-lymphoma-myeloma-leukemia.com/article/S2152-…

medical debt kills. this probably doesn't come as a surprise, but millions of Americans live the consequences of this daily. that's unacceptable. thanks JAMA Network Open for the opportunity 🖊️ and excited for future work ahead 💪🏼 jamanetwork.com/journals/jaman…

1/ Our review of time toxicity in lymphoma & multiple myeloma, led by my Fred Hutchinson Cancer Center neighbor Mengyang Di, MD PhD, now out in Leukemia & Lymphoma! As treatments get better in #lymsm & #MMsm, important to consider time at home in protocols & SOC workflows. tandfonline.com/eprint/HXAE8BY…

Incredibly honored to receive a Career Development Award from Conquer Cancer, the ASCO Foundation! So excited for all the work ahead😊

thank you Fred Hutch Cancer Center for coming by and the comms coverage! 😊